Patent · US Active

Anti-HPV E7 antibodies

US9249212B2 · kind B2 · utility

1Cited by

2References

22Claims

0Family size

Assignees

OSTERREICHISCHE AKADEMIE DER WISSENSCHAFTEN · AT
AUSTRIA WIRTSCHAFTSSERVICE GESELLSCHAFT MBH · AT

Inventors

Pidder Jansen-Durr · Innsbruck, AT
Werner Zwerschke · Innsbruck, AT
Haymo Pircher · Zirl, AT
Daniela Ehehalt · Innsbruck, AT
Barbara Lener · Innsbruck, AT
Kerstin Dreier · Innsbruck, AT

Key dates

Filing date	Feb 16, 2011
Grant date	Feb 2, 2016
Priority date	—
Expiry date	Oct 29, 2031

Classification

Technology area (CPC G)Physics
CPC primaryG01N2469/10
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Monoclonal anti-HPV (human papillomavirus) E7 antibodies are capable of specifically recognizing an epitope of the C-terminal or the N-terminal region of a HPV E7 protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.